Tameron David 4
4 · BKV Corp · Filed Mar 27, 2026
Research Summary
AI-generated summary of this filing
BKV CFO David Tameron Sells 7,300 Shares
What Happened
- David Tameron, Chief Financial Officer of BKV Corp (BKV), disposed of 7,300 shares in an open-market sale on March 27, 2026. The weighted-average sale price was $29.71, generating proceeds of approximately $216,919. The filing reports the sale as a disposition (transaction code S).
Key Details
- Transaction date: 2026-03-27
- Price: weighted-average $29.71; individual sale prices reported in the filing ranged from $29.46 to $29.8450
- Proceeds: ~$216,919
- Method: reported as an open-market or private sale; filing language and footnote indicate a Rule 10b5-1 trading plan governed the transaction
- Footnotes: F1 notes the trade was effected under a Rule 10b5-1 plan adopted Dec 3, 20225 (as reported in the filing). F2 explains the weighted-average price and offers to provide the breakdown of shares sold at each price upon request.
- Shares owned after the transaction: not provided in the excerpt of the filing
Context
- This sale was executed under a Rule 10b5-1 plan, which is a pre-arranged trading program commonly used to schedule insider trades and reduce allegations of trading on nonpublic information. Sales under such plans are generally considered routine and do not, by themselves, indicate management sentiment about the company.
Insider Transaction Report
Form 4
BKV CorpBKV
Tameron David
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-03-27$29.71/sh−7,300$216,919→ 61,925 total
Holdings
- 300(indirect: By Son)
Common Stock
- 300(indirect: By Son)
Common Stock
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 20225.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.46 to $29.8450, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Kathleen Lenox, attorney-in-fact|2026-03-27